Scarica l'app Stockscreener
12.97
1.33%
0.17
Dopo l'orario di chiusura:
12.79
-0.18
-1.39%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Precedente Chiudi:
$12.80
Aprire:
$12.74
Volume 24 ore:
1.65M
Relative Volume:
0.84
Capitalizzazione di mercato:
$1.97B
Reddito:
$177.28M
Utile/perdita netta:
$-195.24M
Rapporto P/E:
-9.6791
EPS:
-1.34
Flusso di cassa netto:
$-114.54M
1 W Prestazione:
+5.49%
1M Prestazione:
+20.65%
6M Prestazione:
+58.95%
1 anno Prestazione:
+179.53%
Intervallo 1D:
$12.63
$13.01
Intervallo di 1 settimana:
$12.10
$13.39
Portata 52W:
$3.981
$13.39
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Nome
Adaptive Biotechnologies Corp
Settore
Industria
Telefono
206-659-0067
Indirizzo
1165 EASTLAKE AVE E, SEATTLE, WA
Confronta ADPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
12.97 | 1.95B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-18 | Iniziato | Craig Hallum | Buy |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-21 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Underperform |
| 2022-06-03 | Iniziato | Piper Sandler | Neutral |
| 2022-02-16 | Reiterato | BTIG Research | Buy |
| 2022-02-16 | Reiterato | BofA Securities | Buy |
| 2022-02-16 | Reiterato | Goldman | Neutral |
| 2022-02-16 | Reiterato | JP Morgan | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-03-03 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Iniziato | Goldman | Buy |
| 2019-07-23 | Iniziato | BTIG Research | Buy |
| 2019-07-22 | Iniziato | BofA/Merrill | Buy |
| 2019-07-22 | Iniziato | Cowen | Outperform |
| 2019-07-22 | Iniziato | Goldman | Neutral |
| 2019-07-22 | Iniziato | Guggenheim | Buy |
| 2019-07-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - The Manila Times
Is Adaptive Biotechnologies Corporation a candidate for recovery playJuly 2025 Spike Watch & Real-Time Volume Spike Alerts - Newser
What MACD signals say about Adaptive Biotechnologies CorporationMarket Activity Report & Reliable Entry Point Trade Alerts - Newser
Top chart patterns to watch in Adaptive Biotechnologies CorporationJuly 2025 News Drivers & Risk Managed Investment Strategies - Newser
How to forecast Adaptive Biotechnologies Corporation trends using time seriesJuly 2025 Catalysts & Smart Swing Trading Alerts - Newser
Market reaction to Adaptive Biotechnologies Corporation’s recent newsPortfolio Growth Summary & Capital Efficiency Focused Ideas - Newser
Regression analysis insights on Adaptive Biotechnologies Corporation performance - Newser
What earnings revisions data tells us about Adaptive Biotechnologies CorporationMarket Trend Summary & Free Expert Approved Momentum Trade Ideas - Newser
How Adaptive Biotechnologies Corporation stock reacts to Fed policy changesGap Down & Expert Approved Trade Ideas - Newser
Multi asset correlation models including Adaptive Biotechnologies Corporation2025 Historical Comparison & Reliable Trade Execution Plans - Newser
Published on: 2025-08-25 21:08:30 - beatles.ru
Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Adaptive Biotechnologies (ADPT) Poised for $33.7M Windfall on Genentech Deal Termination - Insider Monkey
Adaptive Biotechnologies (ADPT): Evaluating Valuation Following Genentech Collaboration Wind-Down and Strategic Refocus - ca.finance.yahoo.com
What technical models suggest about Adaptive Biotechnologies Corporation’s comebackRate Cut & Expert Curated Trade Setup Alerts - Newser
Adaptive Biotechnologies stock hits 52-week high at $13.37 - Investing.com India
Is Adaptive Biotechnologies Corporation backed by strong institutional buying2025 Trading Volume Trends & Real-Time Sentiment Analysis - theviewers.co.kr
How does Adaptive Biotechnologies Corporation compare to its peersTrade Analysis Summary & Proven Capital Preservation Methods - theviewers.co.kr
Is Adaptive Biotechnologies Corporation reversing from oversold territoryJuly 2025 Breakouts & Safe Capital Growth Tips - Newser
Intraday pattern recognizer results for Adaptive Biotechnologies Corporation2025 Major Catalysts & Breakout Confirmation Trade Signals - Newser
How a Genentech cancer-fighting collaboration once valued at $2 billion ended with only $310 million paid out - The Business Journals
Adaptive Biotechnologies to end Genentech collaboration agreement in February 2026 - Investing.com
Real time scanner hits for Adaptive Biotechnologies Corporation explainedQuarterly Trade Review & Safe Entry Point Identification - Newser
Sectors Driving Future Growth for Adaptive Biotechnologies Corporation StockPortfolio Value Report & Risk Adjusted Swing Trade Ideas - Newser
Adaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Adaptive Biotechnologies Outpaces Medical Sector with 109.2% Year-to-Date Gain - AInvest
Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Adaptive Biotechnologies Reaches Analyst Target Price - Nasdaq
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Just Reported And Analysts Have Been Lifting Their Price Targets - ca.finance.yahoo.com
Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences - 富途牛牛
Adaptive Biotechnologies’ Earnings Call Highlights Growth - The Globe and Mail
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q2 2025 Earnings Call Transcript - Insider Monkey
A Quick Look at Today's Ratings for Adaptive Biotechnologies(ADPT.US), With a Forecast Between $14 to $15 - 富途牛牛
Adaptive Biotechnologies Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
JP Morgan Boosts Price Target for ADPT to $14.00, Maintains Over - GuruFocus
JP Morgan Boosts Price Target for ADPT to $14.00, Maintains Overweight Rating | ADPT Stock News - GuruFocus
Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday - Yahoo Finance
JP Morgan Maintains Overweight on Adaptive, Raises PT to $14 from $10 - AInvest
Adaptive Biotechnologies (ADPT) Rating Update: TD Cowen Raises Price Target | ADPT Stock News - GuruFocus
TD Cowen Keeps Buy Rating, Raises PT to $15 on Adaptive Biotechnologies - AInvest
Piper Sandler Raises Price Target for ADPT to $15.00 | ADPT Stock News - GuruFocus
A Quick Look at Today's Ratings for Adaptive Biotechnologies(ADPT.US), With a Forecast Between $11 to $15 - 富途牛牛
Adaptive Biotechnologies stock hits 52-week high at $12.50 - Investing.com India
Adaptive Biotechnologies stock hits 52-week high at $12.50 By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies (ADPT) Price Target Increased by JPMorg - GuruFocus
Adaptive Biotechnologies Exceeds Q2 Expectations Despite LossNews and Statistics - IndexBox
Adaptive Biotechnologies: Q2 Earnings Snapshot - New Haven Register
Adaptive Biotechnologies Corp (ADPT) Q2 2025 Earnings Call Highlights: Strong MRD Growth and ... - Yahoo Finance
Adaptive Biotechnologies Corp (ADPT) Q2 2025 Earnings Call Highl - GuruFocus
Adaptive Biotechnologies Corp (ADPT) Q2 2025 Earnings Call Highlights: Strong MRD Growth and ... By GuruFocus - Investing.com Canada
Advanced analytics toolkit walkthrough for Adaptive Biotechnologies CorporationFree Swing Trading Entry Point Signals - Newser
Adaptive Biotechnologies Corp Azioni (ADPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
8.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):